Vircell – VirClia Monotests for STI Diagnosis
Vircell’s range of VirClia STI monotests are ready-to-use, self-contained monotest assays with all the necessary reagents within the strip, including calibrators and controls. Explore the range below.
Vircell’s range of VirClia STI monotests are ready-to-use, self-contained monotest assays with all the necessary reagents within the strip, including calibrators and controls. Explore the range below.
Vircell 2025 Catalogues*
Infectious Immunology | Molecular Biology – Diagnostic Solutions for Human Infectious Diseases
Discover the latest molecular biology and infectious immunology advancements with the 2025 Vircell Catalogues. Explore cutting-edge products and innovative solutions designed to enhance your research.
Vircell has gotten great results from their internal assessment comparing the Helicobacter pylori Ag VIRCLIA® MONOTEST with other top diagnostic tests in the market. Check out the study below and stay tuned for more updates.
VirClia® Helicobacter pylori Ag Monotest – the fully automated solution for stool antigen detection
Infection with H. pylori is a major cause of gastric and duodenal ulcers, as well as a risk factor for gastric carcinoma and lymphoma. The detection of H. pylori antigen in stool is a reliable method used to aid in the diagnosis of infections in untreated patients.
The Varicella Zoster VirClia Monotest is an indirect chemiluminescent immunoassay to test antibodies against varicella zoster virus in human serum or plasma.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Vircell provides a complete, fully automated platform together with self-contained monotests assays with all the needed reagents in the strip including calibrators and controls.
Products are for professional/laboratory use only. We are happy to announce the launch of the new VirClia® monotest to detect and quantify IgG antibodies against SARS-CoV-2 Spike in human serum or plasma, with strong correlation to neutralizing antibodies.
Over 30 million people are at risk of invasive aspergillosis each year due to use of corticosteroids, chemotherapy or other immunosuppressive agents, and over 300,000 patients develop it annually.1
Products are for professional/laboratory use only.
A fully automated solution for Hepatitis E serology with the VirClia® instruments will allow obtaining results on the same day the sample is collected and avoid batch testing.